pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·May 13·2 min read
save

Opinion: What can ‘blue zones’ really teach us about aging?

Have you heard about blue zones where people tend to live much longer? They’re more complicated than they might sound.

May 13, 2026·read at STAT ↗

PodcastFirst Opinion Podcast What can ‘blue zones’ really teach us about aging? An interview with Eric Topol and Shelley Wood Manage alerts for this article Email this article Share this article By Torie BoschMay 13, 2026 Editor, First Opinion Torie Bosch[email protected]Torie Bosch is the First Opinion editor at STAT. In 2023, Netflix released a documentary titled “Live to 100: Secrets of the Blue Zones,” which looked at some small, geographically isolated places around the world in which, reportedly, residents regularly lived to 100 or beyond.

It was just the most recent installment to a longevity franchise that began roughly 25 years ago. But how real are “blue zones”? And has the concept’s commercialization drowned out its scientific value?Advertisement Medical journalist Shelley Wood, author of the novel “The Leap Year Gene of Kit McKinley,” and cardiologist Eric Topol, author of “Super Agers,” recently teamed up recently to write a First Opinion essay examining blue zones at 25 years.

They joined me on this episode of the “First Opinion Podcast” to discuss their findings and how the idea of blue zones fits into the current longevity craze. They argue that the concept, which originated with mountain villages in Sardinia, Italy, may have been flawed from the start, given how many records were destroyed by World War II — but that it still promotes some valuable ideas, especially in an age of longevity pseudoscience. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts.

Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday. aging, public health Submit a correction requestReprints Torie Bosch Editor, First Opinion Torie Bosch is the First Opinion editor at STAT.

Newsletter Weekly alerts when a new episode drops from STAT’s First Opinion podcast Recommended First Opinion May 13, 2026 Access to air conditioning is critical preventive care. But federal policy treats it as optional First Opinion May 13, 2026 RFK Jr.’s antidepressant deprescribing push gets one thing right — and others dangerously wrong Advertisement Opinions+ May 12, 2026 STAT Plus: Pharma and biotech leaders are destroying their own industry First Opinion May 11, 2026 What addiction medicine can teach us about depending on AI First Opinion May 11, 2026 AI doctors should be licensed. Here’s a framework to do that Subscriber Picks

source

Reporting by STAT.

read at STAT ↗
405 words · retrieved May 13
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
MOUNTAIN

related stories

  • Aug 25How Trump’s cuts are reshaping America’s health systemSTAT
  • Aug 12STAT+: Inside a $7 billion Silicon Valley startup’s mad dash to automate the business of health careSTAT
  • Jul 22As Maui recovers from devastating fires, a study offers vision for new rural health modelSTAT
  • Jul 2STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and moreSTAT
  • Jun 4STAT+: Pharmalittle: We’re reading about fewer pharma investments in Germany, growing U.S. layoffs, and moreSTAT